NCT06323629 Effects of Recursive Self-feedback on Speech Production in Aphasia
| NCT ID | NCT06323629 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of South Florida |
| Condition | Aphasia |
| Study Type | INTERVENTIONAL |
| Enrollment | 45 participants |
| Start Date | 2024-08-29 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 45 participants in total. It began in 2024-08-29 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to test the effects of recursive self-feedback procedures on spontaneous speech production in stroke survivors with impaired speech production (aphasia). The main question it aims to answer is: • To what extent can stroke survivors with aphasia use their self-feedback alone to improve their spontaneous speech production? Participants will be engaged in the following activities: * They will perform language and cognitive tasks. * Afterwards, they will receive treatments using tablets and headphones at no cost to them. * The experimental treatments (recursive self-feedback procedures) entails responding to prompts, listening to playbacks of their speech response and attempt to minimize/correct the errors in the next attempt. This process will be repeated multiple times per prompt. * The experimental treatments are two: an adaptive version that adapts the complexity of the treatment prompt and a non-adaptive version that does not adapt task complexity. * Researchers will compare the experimental treatments to see if both have similar effects on improving spontaneous speech production.
Eligibility Criteria
Inclusion Criteria: * 6 months post left hemisphere stroke * Aphasia due to left hemisphere stroke * Dominant English speaker Exclusion Criteria: * Speech-language deficits due to neurological insults such as Parkinson's disease, neurodegenerative conditions etc. * Uncorrected sensory impairments. * Language comprehension impairment. * Severe cognitive impairment.
Contact & Investigator
Gerald C. Imaezue, PhD
PRINCIPAL INVESTIGATOR
University of South Florida
Frequently Asked Questions
Who can join the NCT06323629 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Aphasia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06323629 currently recruiting?
Yes, NCT06323629 is actively recruiting participants. Contact the research team at gimaezue@usf.com for enrollment information.
Where is the NCT06323629 trial being conducted?
This trial is being conducted at Tampa, United States.
Who is sponsoring the NCT06323629 clinical trial?
NCT06323629 is sponsored by University of South Florida. The principal investigator is Gerald C. Imaezue, PhD at University of South Florida. The trial plans to enroll 45 participants.